New regimen looks good in stage IV favorable histology Wilms

Funders included the National Cancer Institute, National Institutes of Health, and St. Baldrick’s Foundation. Senior author Jeffrey S. Dome, MD, PhD, disclosed intellectual property with Rockland Immunochemicals. Three coinvestigators disclosed ties to healthcare and pharmaceutical companies.

SOURCE: Dix DB et al. J Clin Oncol. 2018 Apr 11. doi: 10.1200/JCO. 2017.77.1931.